U.S. Paper and Forestry Products Stock News

We wouldn't blame UFP Technologies, Inc. ( NASDAQ:UFPT ) shareholders if they were a little worried about the fact that...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

United Natural Foods (UNFI) is drawing investor attention after recent share price moves, with the stock last closing at US$50.57. That price sits alongside an estimated intrinsic discount of 53.39% and a value score of 5. See our latest analysis for United Natural Foods. Recent trading has been a bit choppy, with the share price down 2.11% over one day and 3.34% over seven days. However, the 90 day share price return of 25.48% and year to date share price return of 51.32% point to building...

Investors who take an interest in Strattec Security Corporation ( NASDAQ:STRT ) should definitely note that the Senior...

Mirum Pharmaceuticals reported positive topline VISTAS Phase 2b results for volixibat in primary sclerosing cholangitis related cholestatic pruritus. The trial showed a robust, clinically meaningful improvement in itch symptoms for PSC patients, who currently have no approved treatment options. Following the data, Mirum has a pre NDA meeting scheduled and plans to file for regulatory approval for volixibat. For investors tracking Mirum Pharmaceuticals, ticker NasdaqGM:MIRM, this update sits...

Some Watts Water Technologies, Inc. ( NYSE:WTS ) shareholders may be a little concerned to see that the President of...

Evercore (NYSE:EVR) reported an exceptional first quarter, delivering the fastest revenue growth among its investment banking peers. The company significantly exceeded analyst expectations for the period. Evercore also strengthened its Equities division with the hire of a highly experienced industry veteran to a senior role. Evercore enters this news cycle with the stock at $333.56 and a 1 year return of 39.7%. Despite this, the share price is down 5.0% year to date, 8.1% over the past...

Earlier this week, TD Cowen upgraded FirstEnergy Corp., citing its role as a key transmission provider within the PJM grid and the expected demand uplift from data center power needs. The upgrade also pointed to improved regulatory relationships after a recent SEC settlement, suggesting that governance and oversight concerns may be easing for the utility. We’ll now examine how this improved regulatory backdrop and transmission-focused thesis could reshape FirstEnergy’s existing investment...

Readers hoping to buy Vulcan Materials Company ( NYSE:VMC ) for its dividend will need to make their move shortly, as...

We wouldn't blame Regal Rexnord Corporation ( NYSE:RRX ) shareholders if they were a little worried about the fact that...

Anyone interested in Park-Ohio Holdings Corp. ( NASDAQ:PKOH ) should probably be aware that the Independent Director...

Some W.W. Grainger, Inc. ( NYSE:GWW ) shareholders may be a little concerned to see that the Senior VP & President of...

We wouldn't blame Ducommun Incorporated ( NYSE:DCO ) shareholders if they were a little worried about the fact that...

As you might know, Applied Materials, Inc. ( NASDAQ:AMAT ) just kicked off its latest quarterly results with some very...

While Quanex Building Products Corporation ( NYSE:NX ) might not have the largest market cap around , it received a lot...

Chevron Corporation's ( NYSE:CVX ) recent weak earnings report didn't cause a big stock movement. Our analysis suggests...

We wouldn't blame Oceaneering International, Inc. ( NYSE:OII ) shareholders if they were a little worried about the...

Anyone interested in Harmonic Inc. ( NASDAQ:HLIT ) should probably be aware that the Senior VP & GM of Video Business...

Shareholders in Cytokinetics, Incorporated ( NASDAQ:CYTK ) may be thrilled to learn that the analysts have just...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

Catalyst Pharmaceuticals, ticker NasdaqCM:CPRX, has agreed to be acquired by Angelini Pharma in a definitive all cash transaction. The company has settled all pending Firdapse patent litigation, granting generic licenses that run through 2035. The deal marks an exit for current public shareholders and is set to reshape how Catalyst Pharmaceuticals operates within the rare disease drug market. Catalyst Pharmaceuticals focuses on treatments for rare neurological conditions, with Firdapse as a...

If you are wondering whether Jones Lang LaSalle at around US$288.23 is priced attractively or asking too much for future potential, the stock’s current valuation metrics deserve a closer look. The share price has been under pressure recently, falling 12.6% over the past week and 16.8% over the past month, even though the 1 year return sits at 22.2% and the 3 year return at 100.1%. Recent news coverage has focused on Jones Lang LaSalle as one of the larger listed real estate services...

Hercules Capital (NYSE:HTGC) has promoted longtime CFO Seth H. Meyer to President. Andrew Olson, who has experience in private credit, venture capital and prior roles at Hercules, has been appointed as the new CFO. These leadership changes mark a material shift in the company's executive team and could influence how Hercules Capital is run and where it focuses next. Hercules Capital, a lender focused on venture and growth stage companies, is making these leadership moves while its stock...

If you have been wondering whether Acuity's current share price reflects its true worth, this article walks through what the numbers are actually saying about the stock. Acuity closed at US$281.63 recently, with the share price down 4.0% over the past week, down 3.8% over the past month, but showing gains of 3.4% over 1 year, 78.3% over 3 years and 61.0% over 5 years. Recent coverage of Acuity has focused on how the stock's longer term gains contrast with its more recent pullback, prompting...